Expression of AR-V7 and ARv(567es) in circulating tumor cells correlates with outcomes to taxane therapy in men with metastatic prostate cancer treated in TAXYNERGY

PURPOSE: Biomarkers aiding treatment optimization in metastatic castration-resistant prostate cancer (mCRPC) are scarce. Presence or absence of androgen receptor (AR) splice variants, AR-V7 and AR(v567es), in mCRPC patient circulating tumor cells (CTCs) may be associated with taxane treatment outcom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Principais autores: Tagawa, Scott T., Antonarakis, Emmanuel S., Gjyrezi, Ada, Galletti, Giuseppe, Kim, Seaho, Worroll, Daniel, Stewart, John, Zaher, Atef, Szatrowski, Ted P., Ballman, Karla V., Kita, Katsuhiro, Tasaki, Shinsuke, Bai, Yang, Portella, Luigi, Kirby, Brian J, Saad, Fred, Eisenberger, Mario A., Nanus, David M., Giannakakou, Paraskevi
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6432911/
https://ncbi.nlm.nih.gov/pubmed/30301829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-0320
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados